News

Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund

Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund

HERALD CHRONICLE | Venatorx Pharmaceuticals, Inc., a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial infections and hard-to-treat viral infections, today announced that it sold shares of its Series C Preferred Stock in a financing led by the AMR Action Fund with participation from existing investors including Abingworth.

Full Story